Free Trial

Rithm Capital (RITM) Projected to Post Earnings on Monday

Rithm Capital logo with Finance background

Rithm Capital (NYSE:RITM - Get Free Report) is expected to be releasing its Q2 2025 earnings data before the market opens on Monday, July 28th. Analysts expect Rithm Capital to post earnings of $0.52 per share and revenue of $1.18 billion for the quarter.

Rithm Capital (NYSE:RITM - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The real estate investment trust reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.07. Rithm Capital had a net margin of 15.06% and a return on equity of 18.38%. The company had revenue of $28.89 million during the quarter, compared to the consensus estimate of $1.27 billion. During the same period last year, the firm earned $0.48 EPS. On average, analysts expect Rithm Capital to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Rithm Capital Price Performance

Shares of Rithm Capital stock traded up $0.01 during trading on Thursday, hitting $12.26. 1,269,343 shares of the company were exchanged, compared to its average volume of 4,456,901. The stock has a market capitalization of $6.50 billion, a price-to-earnings ratio of 10.20 and a beta of 1.25. The company has a quick ratio of 0.35, a current ratio of 0.35 and a debt-to-equity ratio of 1.68. Rithm Capital has a fifty-two week low of $9.13 and a fifty-two week high of $12.31. The firm has a 50 day moving average price of $11.47 and a 200 day moving average price of $11.33.

Rithm Capital Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a dividend of $0.25 per share. The ex-dividend date is Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.16%. Rithm Capital's payout ratio is 83.33%.

Hedge Funds Weigh In On Rithm Capital

Several institutional investors have recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. raised its stake in shares of Rithm Capital by 14.3% in the first quarter. Geneos Wealth Management Inc. now owns 7,031 shares of the real estate investment trust's stock worth $81,000 after acquiring an additional 881 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Rithm Capital by 75.6% in the first quarter. Goldman Sachs Group Inc. now owns 1,539,483 shares of the real estate investment trust's stock valued at $17,627,000 after buying an additional 662,585 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Rithm Capital by 5.3% in the first quarter. NewEdge Advisors LLC now owns 31,311 shares of the real estate investment trust's stock valued at $359,000 after buying an additional 1,585 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in Rithm Capital by 20.4% during the first quarter. AQR Capital Management LLC now owns 77,625 shares of the real estate investment trust's stock worth $889,000 after purchasing an additional 13,166 shares during the last quarter. 44.92% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on RITM. Wedbush reissued an "outperform" rating and issued a $14.00 price objective on shares of Rithm Capital in a research report on Monday, May 19th. UBS Group reiterated a "buy" rating and set a $14.00 price objective (up previously from $13.00) on shares of Rithm Capital in a research note on Tuesday, July 15th. BTIG Research restated a "buy" rating and issued a $16.00 target price on shares of Rithm Capital in a research report on Friday, April 25th. Piper Sandler upgraded shares of Rithm Capital from a "neutral" rating to an "overweight" rating and increased their price objective for the company from $12.50 to $14.00 in a report on Monday, April 28th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $13.00 price target on shares of Rithm Capital in a research report on Tuesday, May 20th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $13.69.

Check Out Our Latest Stock Report on Rithm Capital

About Rithm Capital

(Get Free Report)

Rithm Capital Corp. operates as an asset manager focused on real estate, credit, and financial services. It operates through Origination and Servicing, Investment Portfolio, Mortgage Loans Receivable, and Asset Management segments. Its investment portfolio primarily comprises of mortgage servicing rights (MSR), and MSR financing receivables, title, appraisal and property preservation, excess MSRs, and services advance investments; real estate securities, call rights, SFR properties, and residential mortgage loans; consumer and business purpose loans; and asset management related investments.

Further Reading

Earnings History for Rithm Capital (NYSE:RITM)

Should You Invest $1,000 in Rithm Capital Right Now?

Before you consider Rithm Capital, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rithm Capital wasn't on the list.

While Rithm Capital currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines